
Opinion|Videos|May 14, 2024
Strategies to Enhance CDK4/6 Inhibitor Adherence in mBC
Heather Moore, BCOP, CPP, PharmD, discusses patient adherence to CDK4/6 inhibitors in clinical practice, emphasizing the importance of educating patients on drug efficacy and potential toxicities, monitoring for adverse events, and following up with patients to ensure better adherence.
Advertisement
Episodes in this series

Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Regular Melatonin Supplementation May Hide Hidden Heart Complications
2
FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity
3
From Type 1 to Type 2 and Beyond: Navigating the Landscape of Diabetes
4
COVID-19 During Pregnancy Raises Neurodevelopmental Risks in Children
5















































































































































































































